T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Arvinas
ARVN
$580M
| $19.8M | ﹤0.01% |
839,795
-19,230
| -2% | -$557K |
|
|
PCSB
1152
DELISTED
PCSB Financial Corporation
PCSB
| $19.8M | ﹤0.01% |
1,637,024
-1,654
| -0.1% | -$20.3K |
|
1153
Urban Edge Properties
UE
$2.75B
| $19.7M | ﹤0.01% |
2,026,860
+80,819
| +4% | +$861K |
|
|
CYBR
1154
DELISTED
CyberArk
CYBR
| $19.7M | ﹤0.01% |
190,331
-18,758
| -9% | -$2.02M |
|
1155
Nurix Therapeutics
NRIX
$2.76B
| $19.6M | ﹤0.01% |
+562,746
| New | +$14.2M |
|
1156
First Bancorp
FBNC
$2.72B
| $19.6M | ﹤0.01% |
935,553
-16,873
| -2% | -$362K |
|
1157
Hilton Grand Vacations
HGV
$3.49B
| $19.5M | ﹤0.01% |
930,124
-353,941
| -28% | -$7.54M |
|
1158
Seagate
STX
$209B
| $19.5M | ﹤0.01% |
395,482
-34,969
| -8% | -$1.64M |
|
1159
iShares Core MSCI EAFE ETF
IEFA
$196B
| $19.3M | ﹤0.01% |
320,567
+108,078
| +51% | +$6.52M |
|
1160
Advance Auto Parts
AAP
$3.23B
| $19.2M | ﹤0.01% |
125,184
-6,746
| -5% | -$1.02M |
|
1161
International Seaways
INSW
$4.58B
| $19.1M | ﹤0.01% |
1,310,257
+68,471
| +6% | +$1.14M |
|
1162
Citizens Financial Group
CFG
$31.1B
| $19.1M | ﹤0.01% |
754,977
-59,118
| -7% | -$1.5M |
|
1163
Eastman Chemical
EMN
$8.29B
| $19M | ﹤0.01% |
243,079
-8,581
| -3% | -$647K |
|
|
EPZM
1164
DELISTED
Epizyme, Inc
EPZM
| $18.9M | ﹤0.01% |
1,585,052
-442,195
| -22% | -$5.92M |
|
|
BNR
1165
Burning Rock Biotech
BNR
$105M
| $18.9M | ﹤0.01% |
75,369
-3,521
| -4% | -$834K |
|
1166
Blackstone
BX
$112B
| $18.9M | ﹤0.01% |
362,134
-14,796
| -4% | -$792K |
|
1167
Nektar Therapeutics
NKTR
$2.57B
| $18.6M | ﹤0.01% |
74,551
-11,542
| -13% | -$3.63M |
|
1168
Henry Schein
HSIC
$10.1B
| $18.5M | ﹤0.01% |
314,472
-18,645
| -6% | -$1.2M |
|
|
CTRA
1169
DELISTED
Coterra Energy
CTRA
| $18.4M | ﹤0.01% |
1,061,096
-122,631
| -10% | -$2.29M |
|
1170
Lamb Weston
LW
$7.3B
| $18.1M | ﹤0.01% |
272,914
-6,726
| -2% | -$431K |
|
1171
Legend Biotech
LEGN
$3.93B
| $18.1M | ﹤0.01% |
585,508
-263,509
| -31% | -$8.87M |
|
1172
Blackstone Mortgage Trust
BXMT
$2.41B
| $18M | ﹤0.01% |
819,447
+48,405
| +6% | +$1.13M |
|
1173
Diageo
DEO
$52.8B
| $17.7M | ﹤0.01% |
128,691
+1,545
| +1% | +$213K |
|
1174
NetApp
NTAP
$40.2B
| $17.7M | ﹤0.01% |
403,450
-26,533
| -6% | -$1.16M |
|
1175
Lumen
LUMN
$6.6B
| $17.7M | ﹤0.01% |
1,751,187
-66,014
| -4% | -$686K |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.